Cervical cancer hearing
Executive Summary
FDA is expected to testify at Jan. 28 hearing of the House Government Reform/Human Resources Subcommittee on cervical cancer prevention and research. CDC, NCI and CMS have also been invited to the hearing, which will likely include discussion of the effectiveness of condoms in preventing transmission of human papillomavirus. Merck expects to file a BLA for an HPV vaccine in 2005 (1"The Pink Sheet" Dec. 22, 2003, p. 25)...
You may also be interested in...
HPV hearing
House Government Reform/Human Resources Subcommittee hearing Jan. 28 the "best strategies" to prevent human papillomavirus infection has been postponed until Feb. 5 (1"The Pink Sheet" Jan. 5, 2004, In Brief)...
Merck HPV Vaccine BLA Filing Expected In 2005, Four Years Before GSK
Merck's quadrivalent human papilloma virus vaccine could be approved by FDA up to four years before GlaxoSmithKline's HPV vaccine Cervarix is cleared for marketing in the U.S
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.